Company: MVIS
Filing Date: 2025-08-08
Form Type: 10-Q
Source: 0001641172-25-022632
Chunk: 108

Company: MICROVISION, INC.
Filing Date: 2025-08-08
Form: 10-Q
Item: Part I, Item 8
Chunk 108
---
 of cash and cash equivalents and investment securities, available-for-sale
as of June 30, 2025, are as follows (in thousands):

    (in thousands) 
    Amount  
    Percent 
  
    Cash and cash equivalents 
    $74,094  
     81.1%
  
    Less than one year 
     17,313  
     18.9%

    $91,407  
     100.0%

Foreign
Exchange Rate Risk

Our
major contract and collaborative research and development agreements, product sales, and licensing activity payments are currently made
in U.S. dollars or Euros. Changes in the relative value of the U.S. dollar to the Euro and other currencies may affect revenue and other
operating results as expressed in U.S. dollars. In addition, our international subsidiary financial statements are denominated in Euros.
As such, the consolidated financial statements will continue to remain subject to the impact of foreign currency translation as our international
operations continue to expand. In the future, we may enter into foreign currency hedges to offset material exposure to currency fluctuations
when we can adequately determine the timing and amounts of the exposure.

U.S.
policy changes and uncertainty about such changes may increase market volatility and currency exchange rate fluctuations. Given the relative
significance of our European operations, unfavorable fluctuations in relevant exchange rates will negatively impact our financial condition
and results of operations.

ITEM
4. CONTROLS AND PROCEDURES

Under
the supervision and with the participation of our management, including our Principal Executive Officer and Principal Financial Officer,
we have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities
Exchange Act of 1934) as of the end of the period covered by this report and, based on this evaluation, our Principal Executive Officer
and Principal Financial Officer have concluded that these disclosure controls and procedures are effective. There were no changes in
our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Securities Exchange Act of 1934) that
occurred during the quarter ended June 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal
control over financial reporting.

27

PART
II.

ITEM
1. LEGAL PROCEEDINGS

We
are subject to various claims and pending or threatened lawsuits in the normal